A 65-year-old woman with COPD has FEV1 70% predicted, an mMRC score of 2, a CAT score of 11, and no exacerbations in the past year. She is currently using only short-acting salbutamol as needed. According to the 2023 Canadian Thoracic Society COPD pharmacotherapy guideline, which maintenance regimen is most appropriate?